Oscar Health, Inc. (NYSE:OSCR) Given Average Recommendation of "Hold" by Analysts

Key Points

• Analysts maintain a “Hold” consensus on Oscar Health, with eight hold ratings, three buys and one strong buy among 12 analysts. The average 12-month price target is $26.22.
• Oscar Health reported quarterly EPS of $1.10, exceeding the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion.
• Insiders sold approximately 4.24 million shares worth $124.3 million over the past 90 days, while institutional investors own 75.7% of the company.

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have earned a consensus rating of "Hold" from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $26.2222.

Several equities analysts have commented on OSCR shares. Weiss Ratings raised Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. Zacks Research raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Thursday, August 13th. Wall Street Zen upgraded shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. Finally, Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research note on Friday, August 7th.

Insider Buying and Selling at Oscar Health

In other news, Director Mario Schlosser sold 880,000 shares of Oscar Health stock in a transaction dated Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00. Following the completion of the transaction, the director owned 480,866 shares of the company's stock, valued at $14,127,843.08. The trade was a 64.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Richard Blackley sold 18,750 shares of the company's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $31.74, for a total transaction of $595,125.00. Following the completion of the transaction, the chief financial officer owned 56,250 shares in the company, valued at approximately $1,785,375. The trade was a 25.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 4,241,556 shares of company stock worth $124,280,299. 22.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. California State Teachers Retirement System increased its position in shares of Oscar Health by 3,214.2% during the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company's stock valued at $222,543,000 after acquiring an additional 7,567,600 shares in the last quarter. Comprehensive Financial Planning Inc. PA bought a new position in Oscar Health in the 2nd quarter valued at approximately $309,000. AXQ Capital LP purchased a new stake in Oscar Health during the 2nd quarter valued at $1,059,000. Nykredit A S purchased a new stake in Oscar Health during the 2nd quarter valued at $130,000. Finally, Wellington Management Group LLP increased its holdings in shares of Oscar Health by 65.6% in the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock worth $17,217,000 after purchasing an additional 239,109 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Oscar Health stock opened at $32.07 on Friday. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $33.55. The stock's 50 day simple moving average is $30.39 and its two-hundred day simple moving average is $22.61. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market cap of $9.90 billion, a price-to-earnings ratio of 22.91, a PEG ratio of 0.62 and a beta of 2.37.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same quarter in the prior year, the company earned ($0.89) EPS. The business's revenue was up 70.4% compared to the same quarter last year. As a group, analysts expect that Oscar Health will post 1.54 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source